Allianz Asset Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,049
| Closed | -$450K | – | 2166 |
|
|
2021
Q2 | $450K | Buy |
+12,049
| New | +$450K | ﹤0.01% | 1706 |
|
|
2020
Q3 | – | Sell |
-8,290
| Closed | -$210K | – | 1989 |
|
|
2020
Q2 | $210K | Sell |
8,290
-112,008
| -93% | -$2.84M | ﹤0.01% | 1783 |
|
|
2020
Q1 | $2.21M | Sell |
120,298
-49,712
| -29% | -$913K | ﹤0.01% | 1221 |
|
|
2019
Q4 | $3.75M | Sell |
170,010
-36,627
| -18% | -$807K | ﹤0.01% | 1268 |
|
|
2019
Q3 | $3M | Buy |
206,637
+28,425
| +16% | +$412K | ﹤0.01% | 1323 |
|
|
2019
Q2 | $2.81M | Buy |
178,212
+78,015
| +78% | +$1.23M | ﹤0.01% | 1436 |
|
|
2019
Q1 | $1.47M | Sell |
100,197
-10,937
| -10% | -$160K | ﹤0.01% | 1642 |
|
|
2018
Q4 | $1.19M | Buy |
111,134
+86,567
| +352% | +$925K | ﹤0.01% | 1625 |
|
|
2018
Q3 | $375K | Buy |
+24,567
| New | +$375K | ﹤0.01% | 1953 |
|